CDK2 and hepatocellular carcinoma: Some studies have shown that exo-miR-320a suppress HCC cell proliferation, migration and metastasis by inhibiting the activation of MAPK pathway, which can induce EMT and upregulate the expression of cyclin-dependent kinase 2 (CDK2) and matrix metallopeptidase 2 (MMP2) [68].